Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review
- PMID: 40488204
- PMCID: PMC12142069
- DOI: 10.3389/fneur.2025.1558493
Clinical and cognitive assessment in Friedreich ataxia clinical trials: a review
Abstract
Friedreich ataxia (FRDA) is the most common type of inherited ataxia. It is a neurodegenerative disorder characterized by progressive gait and limb ataxia, dysarthria, areflexia, and reduced proprioception and vibration sensation. Although a number of clinical trials have been conducted, there is currently no cure for this disease. In this article we review those clinical trials with a focus on the instruments used as endpoints to assess clinical progression, and discuss the potential benefits of integrating additional measures, including assessments from overlooked domains. We also review tools used to evaluate cognitive functions in individuals with FRDA, particularly those employing quantitative, objective, and time-based measures. We argue for the inclusion of cognitive and speech-related assessments in clinical trials, and examine the potential of developments in cognitive neuroscience and technology to address current measurement challenges and support more accurate and comprehensive evaluation of treatment effects. These innovations have the potential to complement existing approaches, enhance trial design, and advance clinical care.
Keywords: Friedreich’s ataxia; behavioral assessment; clinical trials; cognitive assessment; outcome measures.
Copyright © 2025 Darriba, Munnich, Cardoso-Leite, Funalot and Waszak.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures



Similar articles
-
Longitudinal Study of Cognitive Functioning in Friedreich's Ataxia.J Int Neuropsychol Soc. 2021 Apr;27(4):343-350. doi: 10.1017/S1355617720000958. Epub 2020 Oct 14. J Int Neuropsychol Soc. 2021. PMID: 33050966
-
Robotic and clinical evaluation of upper limb motor performance in patients with Friedreich's Ataxia: an observational study.J Neuroeng Rehabil. 2015 Apr 23;12:41. doi: 10.1186/s12984-015-0032-6. J Neuroeng Rehabil. 2015. PMID: 25900021 Free PMC article.
-
A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol.PLoS One. 2022 Nov 21;17(11):e0269649. doi: 10.1371/journal.pone.0269649. eCollection 2022. PLoS One. 2022. PMID: 36410013 Free PMC article. Clinical Trial.
-
Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales.J Neurochem. 2013 Aug;126 Suppl 1:118-24. doi: 10.1111/jnc.12318. J Neurochem. 2013. PMID: 23859347 Review.
-
Recent Advances in the Treatment Strategies of Friedreich's Ataxia: A Review of Potential Drug Candidates and their Underlying Mechanisms.Curr Pharm Des. 2024;30(19):1472-1489. doi: 10.2174/0113816128288707240404051856. Curr Pharm Des. 2024. PMID: 38638052 Review.
References
Publication types
LinkOut - more resources
Full Text Sources